Ride to Care - Quality of Life With Transportation for RT

NCT03849742 | Withdrawn

• 2 other identifiers: 189820NCI-2019-00448
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

This trial studies how well Uber health intervention works in eliminating transportation barriers for disadvantaged patients with cancer that has spread to nearby tissue, lymph nodes, or other places in the body, undergoing ambulatory palliative radiotherapy. Uber health intervention provides free transportation to disadvantaged patients and may reduce the amount of missed radiotherapy appointments, patient anxiety, and the amount of unplanned emergency department visits, as well as improve quality of life.

Conditions

Locally Advanced Malignant Neoplasm; Metastatic Malignant Neoplasm

Outcome Measures

Primary Outcomes (2)

• Rate of unplanned emergency department (ED) visits

  For each enrolled patient, any unplanned ED visit over the six months from consultation/enrollment will be documented as an event.

  Up to 6 months

• Rate of unplanned hospital admissions

  For each enrolled patient, any unplanned hospital admission the six months from consultation/enrollment will be documented as an event.

  Up to 6 months

Secondary Outcomes (10)

• Change in mean pain score on the European Organization for Research and Treatment of Cancer quality of life questionnaire 30 (EORTC-QLQ-C30)

  Up to 3 years

• Change in mean overall global health status score on the EORTC-QLQ-C30

  Up to 3 years

• Change in functional domain scores on the EORTC-QLQ-C30

  Up to 3 years

• Percentage of participants who completed total treatment

  Up to 3 years

• Median days of treatment delays

  Up to 3 years

Study Arms (1)

Heath services research (Uber rides)

EXPERIMENTAL

Patients receive Uber rides to and from scheduled radiotherapy appointments for up to 6 months.

Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Procedure: Supportive Care

Interventions

Quality-of-Life Assessment OTHER

Ancillary studies

Also known as: Quality of Life Assessment

Heath services research (Uber rides)

Questionnaire Administration OTHER

Ancillary studies

Heath services research (Uber rides)

Supportive Care PROCEDURE

Receive Uber rides

Also known as: Supportive Therapy, Symptom Management, Therapy, Supportive

Heath services research (Uber rides)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Written informed consent (and assent when applicable) obtained from patient or patients's legal representative and ability for patient to comply with the requirements of the study
• Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
• Histologically confirmed locally advanced or metastatic cancer
• Patients who have received prior courses of radiotherapy are eligible
• If patient answers yes to \>= 1/4 of the questions below:
• In the last six months, have you ever delayed seeing a doctor or getting care?
• Do you anticipate having a hard time coming to University of California, San Francisco (UCSF) for radiation therapy due to transportation challenges?
• Does lack of money for transportation expenses (parking, taxi, bus) make it difficult for you to get care quickly for medical problems?
• Does arranging for transportation (driving yourself, getting neighbor or family to drive you) for your cancer treatments make you anxious or worried?"

You may not qualify if:

• Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
• Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
• Patients who are living at a facility such as a nursing home or skilled nursing facility
• Patients who do not live within a 30-mile radius of one of the radiation oncology sites at University of California San Francisco (UCSF)
• Patients who are currently receiving or expected to be receive UCSF affiliated transportation services prior to enrollment onto the study

Sponsors & Collaborators

• University of California, San Francisco: lead

MeSH Terms

Conditions

Neoplasm Metastasis

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Neoplastic Processes; Neoplasms; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Patient Care; Therapeutics; Health Services; Health Care Facilities Workforce and Services

Study Officials

• Steve Braunstein, MD, PhD

  University of California, San Francisco

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 12, 2019
• First Posted: February 21, 2019
• Study Start: May 15, 2019
• Primary Completion: February 4, 2022
• Study Completion: December 31, 2024
• Last Updated: May 14, 2021

Record last verified: 2021-05

Data Sharing

• IPD Sharing: Will not share